These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32323306)

  • 1. Leishmaniasis as an unusual cause of pancytopenia in a patient receiving immunomodulatory therapy for myeloma.
    Camilleri M; Richards H; Pomplun S; Wilson A; Checkley A; Rabin N
    Br J Haematol; 2020 Aug; 190(3):305. PubMed ID: 32323306
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral leishmaniasis: a trip to the Greek Islands is not always idyllic.
    Ju O; Grove DI; Jaksic WJ; Dart GW
    Med J Aust; 2004 Oct; 181(8):446-7. PubMed ID: 15487964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough in the management of visceral leishmaniasis.
    Thakur BB
    J Assoc Physicians India; 2003 Jul; 51():649-51. PubMed ID: 14621030
    [No Abstract]   [Full Text] [Related]  

  • 4. Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib.
    Piro E; Kropp M; Cantaffa R; Lamberti AG; Carillio G; Molica S
    Ann Hematol; 2012 Nov; 91(11):1827-8. PubMed ID: 22584850
    [No Abstract]   [Full Text] [Related]  

  • 5. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
    Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
    Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.
    Murray HW
    Future Microbiol; 2010 Sep; 5(9):1301-3. PubMed ID: 20860475
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced case of PKDL due to delayed treatment: A rare case report.
    Topno RK; Rabi Das VN; Kumar M; Madhukar M; Pandey K; Verma N; Agrawal K; Lal CS; Siddiqui NA; Bimal S; Das P
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008052. PubMed ID: 32203500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases.
    Ziogas DC; Terpos E; Gavriatopoulou M; Migkou M; Fotiou D; Roussou M; Kanellias N; Tatouli I; Eleutherakis-Papaiakovou E; Panagiotidis I; Ntanasis-Stathopoulos I; Kastritis E; Dimopoulos MA
    Leuk Lymphoma; 2018 Apr; 59(4):983-987. PubMed ID: 28782413
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral miltefosine in the treatment of kala-azar.
    Mohan A; Seth S
    Natl Med J India; 2000; 13(4):202-3. PubMed ID: 11002688
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pancytopenia and septic temperatures 1 year after Mediterranean travel in a 29-year-old patient].
    Steinbigler P; Wichert A; Manz C; Höfling B
    Internist (Berl); 1995 Jun; 36(6):608-10. PubMed ID: 7665330
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
    Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
    Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom.
    Patel TA; Scadding GK; Phillips DE; Lockwood DN
    Am J Trop Med Hyg; 2017 Oct; 97(4):1116-1119. PubMed ID: 29031288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunction.
    Kumar N; Pandey K; Das VN; Sinha PK; Topno RK; Verma N; Lal CS; Das P; Bhattacharya SK
    Ann Trop Med Parasitol; 2007 Oct; 101(7):649-51. PubMed ID: 17877883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].
    Gangneux JP; Marty P
    Sante; 2001; 11(4):257-8. PubMed ID: 11861203
    [No Abstract]   [Full Text] [Related]  

  • 15. A perianal ulcer.
    Schmid ML; McKendrick MW; Lobo A; Leach M
    Lancet; 1999 Mar; 353(9156):894. PubMed ID: 10093983
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miltefosine for Indian visceral leishmaniasis.
    Agarwal PK
    N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12606744
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
    Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India.
    Thakur CP; Sinha PK; Singh RK; Hassan SM; Narain S
    Trans R Soc Trop Med Hyg; 2000; 94(6):696-7. PubMed ID: 11198660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.